Constantine Theodoropulos
CEO GO Therapeutics
Constantine co-founded GO Therapeutics in 2014 with the mission to leverage the biology of cancer glycoproteins to create new and powerful cancer therapies. Prior to GO, Constantine was founder and president of Base Pair Group, a strategic consultancy assisting life science companies on strategy, marketing and business development. He is a frequent advisor to senior executives, boards of directors and venture capitalists. He also raised critical funds and awareness for Dana-Farber Cancer Institute’s Center for Adolescent and Young Adult Oncology in its early stages.
Seminars
Thursday 10th September 2026
Which Platform Technologies are Widening the Immunology & Oncology Fields?
2:30 pm
- How much impact has AI/multi-modal data had on current approaches to drug discovery and translational drug development?
- How are we are validating new, and assessing novel versus de-risked targets?
- What type of clinical data would lead the field to reassess assumptions on a target?
